-
公开(公告)号:US11173207B2
公开(公告)日:2021-11-16
申请号:US16302074
申请日:2017-05-19
IPC分类号: A61K39/39 , A61P37/04 , A61K39/385 , A61K39/295 , A61K39/00 , A61K9/107
摘要: The present invention provides methods and compositions for the stimulation of immune responses. In particular, the invention provides methods and compositions for enhancing an immune response to one or more antigens. Compositions and methods of the invention are useful for the treatment and/or prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites, as well as the treatment and/or prevention of cancer and malignant diseases. Compositions and methods of the invention include one or more antigens/immunogens together with an adjuvant formulation comprising an emulsion delivery system in combination with one or more immunostimulatory compounds (e.g., a compound that stimulates the innate immune system (e.g., a toll-like receptor antagonist (e.g., synthetic oligodeoxynucleotides (ODN)))) that enhance immune responses to the one or more antigens/immunogens when administered to a subject. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
-
公开(公告)号:US11083788B2
公开(公告)日:2021-08-10
申请号:US15517916
申请日:2015-10-09
IPC分类号: A61K39/35 , A61K9/107 , A61K9/00 , A61K47/22 , A61K47/44 , A61K47/26 , A61K9/14 , A61K39/29 , C12N7/00 , A61K39/00
摘要: The present invention provides methods and compositions for the stimulation of immune responses and for treating or preventing allergic disease and responses and inflammatory disease and responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses that prevent or treat allergic disease by reducing allergic response. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
-
公开(公告)号:US20190282693A1
公开(公告)日:2019-09-19
申请号:US16302074
申请日:2017-05-19
摘要: The present invention provides methods and compositions for the stimulation of immune responses. In particular, the invention provides methods and compositions for enhancing an immune response to one or more antigens. Compositions and methods of the invention are useful for the treatment and/or prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites, as well as the treatment and/or prevention of cancer and malignant diseases. Compositions and methods of the invention include one or more antigens/immunogens together with an adjuvant formulation comprising an emulsion delivery system in combination with one or more immunostimulatory compounds (e.g., a compound that stimulates the innate immune system (e.g., a toll-like receptor antagonist (e.g., synthetic oligodeoxynucleotides (ODN)))) that enhance immune responses to the one or more antigens/immunogens when administered to a subject. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
-
公开(公告)号:US09801842B2
公开(公告)日:2017-10-31
申请号:US14299350
申请日:2014-06-09
发明人: James R. Baker, Jr. , Sivaprakash Rathinavelu , Paul E. Makidon , John J. LiPuma , Shraddha Nigavekar
IPC分类号: A61K31/198 , A61K47/32 , A61K33/14 , A61K45/06 , A61K6/00 , A61K9/00 , A61K9/107 , A61K31/22 , A61K31/337 , A61K31/573 , A61K31/7048 , B82Y5/00 , A01N25/04 , A23L29/10 , A23L33/135
CPC分类号: A61K31/198 , A01N25/04 , A23L29/10 , A23L33/135 , A23V2002/00 , A61K6/0008 , A61K9/0078 , A61K9/1075 , A61K31/22 , A61K31/337 , A61K31/573 , A61K31/7048 , A61K33/14 , A61K45/06 , A61K47/32 , B82Y5/00 , A23V2200/25
摘要: The present invention relates to methods and compositions for treating pulmonary infection. In particular, the present invention provides nanoemulsion compositions and methods of using the same to treat bacteria associated with biofilms (e.g., found in pulmonary infections). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
-
公开(公告)号:US09259407B2
公开(公告)日:2016-02-16
申请号:US14628886
申请日:2015-02-23
发明人: James R. Baker, Jr. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica Ann Knowlton , Paul E. Makidon , Luz Blanco , Jeffery V. Groom, II , Anna U. Bielinska
IPC分类号: A61K9/107 , A01N25/04 , A61K45/06 , A61K31/198
CPC分类号: A61K31/198 , A61K9/1075 , A61K31/045 , A61K31/047 , A61K31/14 , A61K31/341 , A61K31/4425 , A61K45/06
摘要: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
-
公开(公告)号:US08980907B2
公开(公告)日:2015-03-17
申请号:US14107817
申请日:2013-12-16
发明人: James R. Baker, Jr. , Xue-min Cheng , Abraham F. L. Van Der Spek , Baohua Mark Huang , Thommey P. Thomas
IPC分类号: A61K31/5513 , A61K31/485 , A61K31/5377 , C07D489/02 , C07D413/06 , A61K47/48
CPC分类号: A61K47/483 , A61K31/485 , A61K47/595
摘要: The present invention relates to novel therapeutic and diagnostic dendrimers. In particular, the present invention is directed to dendrimer-linker conjugates, methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer-linker conjugates of the present invention may further comprise one or more components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy.
摘要翻译: 本发明涉及新的治疗和诊断树枝状大分子。 特别地,本发明涉及树枝状大分子 - 连接体缀合物,其合成方法,包含缀合物的组合物,以及利用缀合物的系统和方法(例如,在诊断和/或治疗设置(例如,用于递送 治疗,成像和/或靶向剂(例如,在疾病(例如癌症)诊断和/或治疗,疼痛治疗等中))。因此,本发明的树枝状大分子 - 接头缀合物还可包含一种或多种 用于靶向,成像,感测和/或提供治疗或诊断材料和/或监测治疗反应的组分。
-
公开(公告)号:US11806318B2
公开(公告)日:2023-11-07
申请号:US17368366
申请日:2021-07-06
IPC分类号: A61K39/35 , A61K9/107 , A61K9/00 , A61K47/22 , A61K47/44 , A61K47/26 , A61K9/14 , A61K39/00 , A61K39/29 , C12N7/00
CPC分类号: A61K39/35 , A61K9/0043 , A61K9/1075 , A61K9/143 , A61K39/292 , A61K47/22 , A61K47/26 , A61K47/44 , C12N7/00 , A61K2039/543 , A61K2039/545 , A61K2039/55505 , A61K2039/55511 , A61K2039/55566 , A61K2039/57 , C12N2730/10134
摘要: The present invention provides methods and compositions for the stimulation of immune responses and for treating or preventing allergic disease and responses and inflammatory disease and responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses that prevent or treat allergic disease by reducing allergic response. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
-
公开(公告)号:US20160025723A1
公开(公告)日:2016-01-28
申请号:US14774578
申请日:2014-03-12
发明人: Sascha N. Goonewardena , Christopher Gasper , James R. Baker, Jr. , Pascale R. Leroueil , Huai Ning Chang
IPC分类号: G01N33/561
CPC分类号: G01N33/561 , G01N27/44739 , G01N33/54366 , G01N33/6803
摘要: The present invention provides microfluidic devices, systems, and methods for use in immunoblotting applications. I particular, devices and methods provided herein have the advantages of traditional Western blotting with increased throughput and multiplex ability, and decreased time, sample, and reagent requirements.
摘要翻译: 本发明提供用于免疫印迹应用的微流体装置,系统和方法。 具体而言,本文提供的传统蛋白质印迹具有增加的生产量和多重能力,减少时间,样品和试剂要求的优点。
-
公开(公告)号:US12076397B2
公开(公告)日:2024-09-03
申请号:US16300423
申请日:2017-05-10
IPC分类号: A61K39/395 , A61K9/00 , A61K9/107 , A61K38/38 , A61K39/12 , A61K39/145 , A61K39/39 , A61K47/10 , A61K47/18 , A61K47/26 , A61K47/34 , A61K39/00
CPC分类号: A61K39/39 , A61K9/0019 , A61K9/0043 , A61K9/107 , A61K38/38 , A61K39/12 , A61K39/145 , A61K47/10 , A61K47/186 , A61K47/26 , A61K47/34 , A61K2039/54 , A61K2039/55566
摘要: The present invention provides compositions comprising emulsion adjuvant and one or more active agents or substances formulated for infusion or injection into a subject (e.g., using a syringe and needle), as well as methods of formulating and using the same (e.g., as an injectable medicinal composition (e.g., a vaccine)). The emulsion adjuvant of an immunogenic composition of the invention in its preferred form comprises a cationic lipid containing a polar head group and a hydrophobic component (e.g., a dual chain hydrophobic group (e.g., the cationic surfactant dioctadecyl dimethyl ammonium chloride (DODAC) and dioctadecyl dimethyl ammonium bromine (DODAB))). Compositions of the invention comprising emulsion adjuvant and one or more active agents or substances formulated for administration via injection to a subject find use in treatment and/or prevention of infectious disease, cancer and/or allergy.
-
公开(公告)号:US20160158179A1
公开(公告)日:2016-06-09
申请号:US15041173
申请日:2016-02-11
发明人: James R. Baker, Jr. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica Ann Knowlton , Paul E. Makidon , Luz Blanco , Jeffery V. Groom, II , Anna U. Bielinska
IPC分类号: A61K31/198 , A61K31/4425 , A61K45/06 , A61K31/047 , A61K31/14 , A61K9/107 , A61K31/341 , A61K31/045
CPC分类号: A61K31/198 , A61K9/1075 , A61K31/045 , A61K31/047 , A61K31/14 , A61K31/341 , A61K31/4425 , A61K45/06
摘要: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
-
-
-
-
-
-
-
-
-